Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

GPS collars 'can monitor response to treatment'
Collie Max with GPS collar
Edinburgh vets hope to use GPS collars in future to learn more about how physical activity affects disease.

Vets study the effect of medication on dogs with osteoathritis

GPS technology could be used by vets to monitor the effects of certain medications. In a recent study, Edinburgh vets used GPS collars to determine the effects of painkillers in dogs with osteoarthritis.

Using the technology, vets from the Royal (Dick) School of Veterinary Studies were able to compare the movements of healthy dogs, to those of dogs with osteoarthritis.

According to their findings, published in the journal PLOS One, dogs treated with the anti-inflammatory painkiller Carprofen could run in nearly the same way as healthy dogs.

Lead researcher Dr Dylan Clements, said: "GPS collars have given us an insight into the levels of physical performance dogs exhibit during their normal daily activities, and show us how much we can alter a dog’s performance by keeping them on or off a lead, or playing with them.
 
"We found that they were a sensitive way for us to measure how well dogs recover from a disease that affects activity, such as osteoarthritis. We hope to be able to use the collars to understand more about how activity might contribute to or help prevent diseases in the future."

The collars allowed vets to monitor how quickly the dogs moved and changed speed, as well as how far they travelled during their normal exercise regime.

According to data collected from the collars, the dogs with osteoarthritis were able to run as quickly as healthy dogs, but their condition significantly affected their ability to speed up and slow down.

When they were treated with Carprofen, however, their performance improved to a level comparable to that of the healthy dogs for most of the measures taken during the study.

To view the research, visit: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117094
 

Image © Dr Stephen Ellwood, Royal (Dick) School of Veterinary Studies

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.